A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck

NCT02775370 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Adenoid Cystic Carcinoma

Interventions

DRUG: Apatinib Mesylate

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University